EE200200193A - Puriinderivaadid - Google Patents

Puriinderivaadid

Info

Publication number: EE200200193A
Authority: EE; Estonia
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

EEP200200193A

Other languages

English (en)

Inventor

Marina Monaghan Sandra

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2000-10-06

Publication date

2003-06-16

2000-10-06 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2003-06-16 Publication of EE200200193A publication Critical patent/EE200200193A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

EEP200200193A 1999-10-14 2000-10-06 Puriinderivaadid EE200200193A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9924363.6A GB9924363D0 (en)	1999-10-14	1999-10-14	Purine derivatives
PCT/IB2000/001444 WO2001027130A1 (en)	1999-10-14	2000-10-06	Purine derivatives

Publications (1)

Publication Number	Publication Date
EE200200193A true EE200200193A (et)	2003-06-16

Family

ID=10862760

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200193A EE200200193A (et)	1999-10-14	2000-10-06	Puriinderivaadid

Country Status (50)

Country	Link
US (1)	US6350735B1 (et)
EP (1)	EP1220863B1 (et)
JP (1)	JP3994007B2 (et)
KR (1)	KR20020037774A (et)
CN (1)	CN1151167C (et)
AP (1)	AP1442A (et)
AR (1)	AR023275A1 (et)
AT (1)	ATE238336T1 (et)
AU (1)	AU768308B2 (et)
BG (1)	BG106569A (et)
BR (1)	BR0011776A (et)
CA (1)	CA2387531C (et)
CO (1)	CO5251399A1 (et)
CR (1)	CR6584A (et)
CZ (1)	CZ20021223A3 (et)
DE (1)	DE60002356T2 (et)
DK (1)	DK1220863T3 (et)
DZ (1)	DZ3159A1 (et)
EA (1)	EA004655B1 (et)
EC (1)	ECSP003712A (et)
EE (1)	EE200200193A (et)
ES (1)	ES2193990T3 (et)
GB (1)	GB9924363D0 (et)
GE (1)	GEP20043269B (et)
GT (1)	GT200000172A (et)
HK (1)	HK1047110B (et)
HN (1)	HN2000000204A (et)
HU (1)	HUP0203483A2 (et)
IL (1)	IL146342A0 (et)
IS (1)	IS6165A (et)
MA (1)	MA26828A1 (et)
MX (1)	MXPA02003812A (et)
MY (1)	MY136242A (et)
NO (1)	NO20021692D0 (et)
NZ (1)	NZ515323A (et)
OA (1)	OA12059A (et)
PA (1)	PA8503501A1 (et)
PE (1)	PE20010755A1 (et)
PL (1)	PL354932A1 (et)
PT (1)	PT1220863E (et)
SI (1)	SI1220863T1 (et)
SK (1)	SK4842002A3 (et)
SV (1)	SV2002000198A (et)
TN (1)	TNSN00202A1 (et)
TR (1)	TR200200985T2 (et)
UA (1)	UA66945C2 (et)
UY (1)	UY26397A1 (et)
WO (1)	WO2001027130A1 (et)
YU (1)	YU88901A (et)
ZA (1)	ZA200202849B (et)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7427606B2 (en) *	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) *	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
BR0209986A (pt) *	2001-05-25	2004-04-06	Pfizer	Agonista de a2a em combinação com um agente anticolinérgico, para o tratamento de doenças obstrutivas das vias respiratórias
NZ532062A (en) *	2001-10-01	2006-09-29	Univ Virginia	2-propynyl adenosine analogues having A2 adenosine recepter agonist activity and compositions thereof to treat inflammatory responses
WO2003086408A1 (en) *	2002-04-10	2003-10-23	University Of Virginia Patent Foundation	Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US20050033044A1 (en)	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
JP5046930B2 (ja) *	2004-08-02	2012-10-10	ユニバーシティオブバージニアパテントファウンデーション	Ａ２ａアゴニスト活性を有する修飾５’−リボース基を備えた２−プロピニルアデノシン類似体
WO2006023272A1 (en) *	2004-08-02	2006-03-02	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having a2a agonist activity
WO2006028618A1 (en) *	2004-08-02	2006-03-16	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
WO2006134487A1 (en) *	2005-06-15	2006-12-21	Pfizer Limited	3-phenylazetidine derivatives as dopamine agonists
CN100352823C (zh) *	2005-08-19	2007-12-05	浙江车头制药有限公司	一种腺嘌呤衍生物的制备方法
JP5006330B2 (ja)	2005-10-21	2012-08-22	ノバルティスアーゲー	Ｉｌ１３に対するヒト抗体および治療的使用
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
US20080027022A1 (en) *	2006-02-08	2008-01-31	Linden Joel M	Method to treat gastric lesions
WO2007120972A2 (en)	2006-02-10	2007-10-25	University Of Virginia Patent Foundation	Method to treat sickle cell disease
US8188063B2 (en) *	2006-06-19	2012-05-29	University Of Virginia Patent Foundation	Use of adenosine A2A modulators to treat spinal cord injury
KR20090073121A (ko)	2006-09-29	2009-07-02	노파르티스 아게	Ｐｉ3ｋ 지질 키나제 억제제로서의 피라졸로피리미딘
US20100041662A1 (en)	2006-10-30	2010-02-18	Sandrine Ferrand	Heterocyclic compounds as antiinflammatory agents
US8058259B2 (en) *	2007-12-20	2011-11-15	University Of Virginia Patent Foundation	Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
WO2009087224A1 (en)	2008-01-11	2009-07-16	Novartis Ag	Pyrimidines as kinase inhibitors
TW201031406A (en)	2009-01-29	2010-09-01	Novartis Ag	Substituted benzimidazoles for the treatment of astrocytomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru)	2009-08-12	2012-09-28	Новартис Аг	Гетероциклические гидразоны и их применение для лечения рака и воспаления
CN102573846B (zh)	2009-08-17	2015-10-07	因特利凯公司	杂环化合物及其用途
MX2012002179A (es)	2009-08-20	2012-03-16	Novartis Ag	Compuestos heterociclicos de oxima.
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
US9127000B2 (en)	2011-02-23	2015-09-08	Intellikine, LLC.	Heterocyclic compounds and uses thereof
JP5959541B2 (ja)	2011-02-25	2016-08-02	ノバルティスアーゲー	Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
EP2755976B1 (en)	2011-09-15	2018-07-18	Novartis AG	6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors
CA2856803A1 (en)	2011-11-23	2013-05-30	Intellikine, Llc	Enhanced treatment regimens using mtor inhibitors
ES2894830T3 (es)	2012-04-03	2022-02-16	Novartis Ag	Productos combinados con inhibidores de tirosina·cinasa y su uso
CN105246482A (zh)	2013-03-15	2016-01-13	因特利凯有限责任公司	激酶抑制剂的组合及其用途
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
KR20170036037A (ko)	2014-07-31	2017-03-31	노파르티스 아게	조합 요법
CN113194752A (zh)	2018-06-01	2021-07-30	康奈尔大学	Pi3k相关疾病或病症的组合疗法
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
WO1988003147A1 (en) *	1986-10-31	1988-05-05	Warner-Lambert Company	Selected n6-substituted adenosines having selective a2 binding activity
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
ATE331726T1 (de) *	1998-10-16	2006-07-15	Pfizer	Adenine-derivate

1999
- 1999-10-14 GB GBGB9924363.6A patent/GB9924363D0/en not_active Ceased
2000
- 2000-09-14 HN HN2000000204A patent/HN2000000204A/es unknown
- 2000-09-26 PA PA20008503501A patent/PA8503501A1/es unknown
- 2000-10-06 PT PT00964566T patent/PT1220863E/pt unknown
- 2000-10-06 SI SI200030102T patent/SI1220863T1/xx unknown
- 2000-10-06 DK DK00964566T patent/DK1220863T3/da active
- 2000-10-06 CA CA002387531A patent/CA2387531C/en not_active Expired - Fee Related
- 2000-10-06 BR BR0011776-5A patent/BR0011776A/pt not_active IP Right Cessation
- 2000-10-06 EE EEP200200193A patent/EE200200193A/et unknown
- 2000-10-06 ES ES00964566T patent/ES2193990T3/es not_active Expired - Lifetime
- 2000-10-06 MX MXPA02003812A patent/MXPA02003812A/es active IP Right Grant
- 2000-10-06 HU HU0203483A patent/HUP0203483A2/hu unknown
- 2000-10-06 EA EA200101107A patent/EA004655B1/ru not_active IP Right Cessation
- 2000-10-06 DE DE60002356T patent/DE60002356T2/de not_active Expired - Fee Related
- 2000-10-06 GE GEAP20006243A patent/GEP20043269B/en unknown
- 2000-10-06 KR KR1020027004748A patent/KR20020037774A/ko not_active Abandoned
- 2000-10-06 EP EP00964566A patent/EP1220863B1/en not_active Expired - Lifetime
- 2000-10-06 HK HK02108605.8A patent/HK1047110B/zh not_active IP Right Cessation
- 2000-10-06 JP JP2001530348A patent/JP3994007B2/ja not_active Expired - Fee Related
- 2000-10-06 CN CNB008096287A patent/CN1151167C/zh not_active Expired - Fee Related
- 2000-10-06 TR TR2002/00985T patent/TR200200985T2/xx unknown
- 2000-10-06 UA UA2002042943A patent/UA66945C2/uk unknown
- 2000-10-06 DZ DZ003159A patent/DZ3159A1/xx active
- 2000-10-06 AP APAP/P/2002/002478A patent/AP1442A/en active
- 2000-10-06 NZ NZ515323A patent/NZ515323A/en unknown
- 2000-10-06 WO PCT/IB2000/001444 patent/WO2001027130A1/en not_active Ceased
- 2000-10-06 IL IL14634200A patent/IL146342A0/xx unknown
- 2000-10-06 SK SK484-2002A patent/SK4842002A3/sk unknown
- 2000-10-06 CZ CZ20021223A patent/CZ20021223A3/cs unknown
- 2000-10-06 YU YU88901A patent/YU88901A/sh unknown
- 2000-10-06 OA OA1200200102A patent/OA12059A/en unknown
- 2000-10-06 AU AU75488/00A patent/AU768308B2/en not_active Ceased
- 2000-10-06 AT AT00964566T patent/ATE238336T1/de not_active IP Right Cessation
- 2000-10-06 PL PL00354932A patent/PL354932A1/xx not_active Application Discontinuation
- 2000-10-12 CO CO00077985A patent/CO5251399A1/es not_active Application Discontinuation
- 2000-10-12 MY MYPI20004790A patent/MY136242A/en unknown
- 2000-10-12 EC EC2000003712A patent/ECSP003712A/es unknown
- 2000-10-12 GT GT200000172A patent/GT200000172A/es unknown
- 2000-10-13 AR ARP000105421A patent/AR023275A1/es unknown
- 2000-10-13 TN TNTNSN00202A patent/TNSN00202A1/fr unknown
- 2000-10-13 SV SV2000000198A patent/SV2002000198A/es unknown
- 2000-10-13 PE PE2000001098A patent/PE20010755A1/es not_active Application Discontinuation
- 2000-10-13 UY UY26397A patent/UY26397A1/es not_active Application Discontinuation
- 2000-10-16 US US09/688,624 patent/US6350735B1/en not_active Expired - Fee Related
2001
- 2001-11-16 IS IS6165A patent/IS6165A/is unknown
2002
- 2002-02-08 CR CR6584A patent/CR6584A/es not_active Application Discontinuation
- 2002-04-02 BG BG106569A patent/BG106569A/xx unknown
- 2002-04-09 MA MA26590A patent/MA26828A1/fr unknown
- 2002-04-10 NO NO20021692A patent/NO20021692D0/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202849A patent/ZA200202849B/xx unknown

Also Published As

Publication number	Publication date
MY136242A (en)	2008-08-29
PL354932A1 (en)	2004-03-22
AU7548800A (en)	2001-04-23
CR6584A (es)	2004-01-14
SV2002000198A (es)	2002-02-05
GT200000172A (es)	2002-04-05
DK1220863T3 (da)	2003-08-11
CA2387531A1 (en)	2001-04-19
PE20010755A1 (es)	2001-07-17
BR0011776A (pt)	2002-03-12
US6350735B1 (en)	2002-02-26
JP3994007B2 (ja)	2007-10-17
MXPA02003812A (es)	2002-09-30
ZA200202849B (en)	2003-06-25
CN1358192A (zh)	2002-07-10
OA12059A (en)	2006-05-03
HUP0203483A2 (hu)	2003-02-28
JP2003511459A (ja)	2003-03-25
CN1151167C (zh)	2004-05-26
CA2387531C (en)	2006-12-05
GEP20043269B (en)	2004-06-25
GB9924363D0 (en)	1999-12-15
ATE238336T1 (de)	2003-05-15
HK1047110A1 (en)	2003-02-07
YU88901A (sh)	2004-09-03
ES2193990T3 (es)	2003-11-16
AP2002002478A0 (en)	2002-06-30
EP1220863B1 (en)	2003-04-23
TNSN00202A1 (fr)	2005-11-10
BG106569A (en)	2002-12-29
SI1220863T1 (en)	2003-10-31
TR200200985T2 (tr)	2002-10-21
AR023275A1 (es)	2002-09-04
NZ515323A (en)	2003-10-31
DE60002356T2 (de)	2004-02-19
EA200101107A1 (ru)	2002-10-31
ECSP003712A (es)	2002-05-23
CZ20021223A3 (cs)	2003-05-14
IS6165A (is)	2001-11-16
DZ3159A1 (fr)	2001-04-19
WO2001027130A1 (en)	2001-04-19
KR20020037774A (ko)	2002-05-22
IL146342A0 (en)	2002-07-25
CO5251399A1 (es)	2003-02-28
AP1442A (en)	2005-06-29
SK4842002A3 (en)	2003-06-03
NO20021692L (no)	2002-04-10
NO20021692D0 (no)	2002-04-10
UA66945C2 (uk)	2004-06-15
HK1047110B (zh)	2005-03-04
EA004655B1 (ru)	2004-06-24
EP1220863A1 (en)	2002-07-10
HN2000000204A (es)	2001-06-21
PT1220863E (pt)	2003-07-31
MA26828A1 (fr)	2004-12-20
UY26397A1 (es)	2001-05-31
PA8503501A1 (es)	2002-02-21
DE60002356D1 (de)	2003-05-28
AU768308B2 (en)	2003-12-04

Publication	Publication Date	Title
DE60026861D1 (de)	2006-05-11	Purin-derivate
DK1220863T3 (da)	2003-08-11	Purinderivater
NO20016109D0 (no)	2001-12-14	Purinderivater
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
DE60119492D1 (de)	2006-06-14	Purinderivate
DK1296996T3 (da)	2004-08-16	Purinderivater
NO20000885L (no)	2000-08-25	4-Fenyl-pyridin-derivater
NO20021077L (no)	2002-03-05	Amino-triazolopyridin-derivater
DE60009747D1 (de)	2004-05-13	Admantan-derivate
ATE293104T1 (de)	2005-04-15	Thiazolylamid-derivate
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
ATE293592T1 (de)	2005-05-15	Resorcinderivate
ATE254598T1 (de)	2003-12-15	4-hydroxybiphenylhydrazid-derivate
DE60001736D1 (de)	2003-04-24	1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate
DK1090019T3 (da)	2005-02-07	Adenosinderivater